Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
16/12/2025 12:06
Dec 16 (Reuters) - Adagene Inc 978y.F: ADAGENE ANNOUNCES FDA FAST TRACK DESIGNATION FOR MUZASTOTUG (ADG126) Source text: ID:nGNX9pPQPD Further company coverage: [978y.F] ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagene
See all newsBrief: Adagene Inc Announces Offering Of American Depositary Shares
Brief: Adagene Announces FDA Fast Track Designation For Muzastotug (Adg126)
Brief: Adagene Expands SAFEBody Deal With Exelixis To Develop Third Novel Masked Antibody-Drug Conjugate
Brief: Adagene Inc - Partners With Conjugatebio For Antibody Drug Conjugate Development
Brief: Adagene Announces Up To $25 Million Strategic Investment From Sanofi